Hamilton Lane Advisors LLC Precision Biosciences Inc Transaction History

Hamilton Lane Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jun 03, 2024	BUY	$0.34 - $0.69 $26,892 - $54,576	79,096 New	79,096 $26,000
Q2 2023 Jun 03, 2024	BUY	$0.52 - $0.91 $41,129 - $71,977	79,096 New	79,096 $41,000
Q1 2023 May 28, 2024	BUY	$0.7 - $1.41 $55,367 - $111,525	79,096 New	79,096 $59,000
Q4 2019 Jan 31, 2020	SELL	$6.32 - $19.66 $1.23 Million - $3.83 Million	-195,000 Reduced 71.14%	79,096 $1.1 Million
Q2 2019 Jul 29, 2019	BUY	$11.88 - $16.94 $3.26 Million - $4.64 Million	274,096 New	274,096 $3.63 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $584M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Lane Advisors LLC with notifications on news.